Search results for "RADIATION"

showing 10 items of 5298 documents

Transitional cell carcinoma of endometrium: a case report of rare pure form

2018

Transitional cell carcinoma is a very rare histological subtype of endometrial cancer, with only 18 cases described in literature. Ovary represents the most common site where it accounts for 2% of all ovarian cancers. Due to the rarity of this disease, current management is controversial and includes various approaches, mostly described in the adjuvant setting, both radiotherapy and chemotherapy alone or in combination. Here, we report a case of a 65-year-old patient who underwent adjuvant vaginal brachytherapy for an endometrial transitional cell carcinoma. The patient was treated with radical total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH-BSO), without lymph-node sa…

medicine.medical_specialtymedicine.medical_treatmentBrachytherapybrachytherapylcsh:MedicineCase ReportEndometrial Transitional Cell CarcinomaEndometrium03 medical and health sciences0302 clinical medicinetransitional cell carcinomamedicineRadiology Nuclear Medicine and imagingendometriumChemotherapyGenitourinary systembusiness.industryEndometrial cancergynecologylcsh:Rmedicine.diseaseRadiation therapymedicine.anatomical_structureTransitional cell carcinomaOncology030220 oncology & carcinogenesisRadiologybusiness030217 neurology & neurosurgeryJournal of Contemporary Brachytherapy
researchProduct

Commissioning and quality assurance procedures for the HDR Valencia skin applicators

2016

The Valencia applicators (Nucletron, an Elekta company, Elekta AB, Stockholm, Sweden) are cup-shaped tungsten applicators with a flattening filter used to collimate the radiation produced by a high-dose-rate (HDR) 192 Ir source, and provide a homogeneous absorbed dose at a given depth. This beam quality provides a good option for the treatment of skin lesions at shallow depth (3-4 mm). The user must perform commissioning and periodic testing of these applicators to guarantee the proper and safe delivery of the intended absorbed dose, as recommended in the standards in radiation oncology. In this study, based on AAPM and GEC-ESTRO guidelines for brachytherapy units and our experience, a set …

medicine.medical_specialtymedicine.medical_treatmentBrachytherapybrachytherapylcsh:MedicineCollimated light030218 nuclear medicine & medical imaging03 medical and health sciences192Ir0302 clinical medicine<SUP>192</SUP>IrmedicineDosimetryRadiology Nuclear Medicine and imagingMedical physicscommissioningRadiation treatment planningQAReview Paperdosimetrybusiness.industryValencia applicatorslcsh:RVisual inspectionOncologyHomogeneous030220 oncology & carcinogenesisAbsorbed dosebusinessQuality assuranceJournal of Contemporary Brachytherapy
researchProduct

Sphenoid sinus mucocele : an unusual complication of head and neck irradiation in a North African woman

2019

Mucocele is a common benign lesion otherwise rarely located in the sphenoid sinus. Some complications after head and neck irradiation have been described in the literature until now. To our knowledge, this is the first report of a sphenoid sinus mucocele in a North African patient treated some years before with radiotherapy for a nasopharyngeal carcinoma (NPC). We extend the literature review about this infrequent finding, of which head and neck surgeons should be aware. Key words:Mucocele, sphenoid sinus mucocele, nasopharyngeal carcinoma, radiotherapy, North African.

medicine.medical_specialtymedicine.medical_treatmentCase Report03 medical and health sciences0302 clinical medicinemedicineotorhinolaryngologic diseasesMucocele030223 otorhinolaryngologyHead and neckGeneral DentistrySinus (anatomy)Mucocele sphenoid sinus mucocele nasopharyngeal carcinoma radiotherapy North Africanbusiness.industryHead and neck irradiationmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Radiation therapymedicine.anatomical_structureNasopharyngeal carcinoma030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASNorth africanRadiologyOral SurgerybusinessComplication
researchProduct

Management of refractory angina: an update.

2020

Abstract Despite the use of anti-anginal drugs and/or percutaneous coronary interventions (PCI) or coronary artery bypass grafting, the proportion of patients with coronary artery disease who have daily or weekly angina ranges from 2% to 24%. Refractory angina refers to long-lasting symptoms (for &amp;gt;3 months) due to established reversible ischaemia, which cannot be controlled by escalating medical therapy with the use of 2nd- and 3rd-line pharmacological agents, bypass grafting, or stenting. While there is uncertain prognostic benefit, the treatment of refractory angina is important to improve the quality of life of the patients affected. This review focuses on conventional pharmacolog…

medicine.medical_specialtymedicine.medical_treatmentChronic coronary syndromeStemcell therapyCoronary Artery Disease030204 cardiovascular system & hematologyRevascularizationAngina PectorisAnginaCoronary artery disease03 medical and health sciencesCoronary artery bypass surgery0302 clinical medicinePercutaneous Coronary InterventionRestenosisInternal medicinemedicineMyocardial RevascularizationHumanscardiovascular diseases030212 general & internal medicineCoronary Artery BypassCoronary sinusbusiness.industryPercutaneous coronary interventionAnginamedicine.diseaseRadiation therapyChronic total occlusionSpinal cord stimulationConventional PCICardiologyQuality of LifeCardiology and Cardiovascular MedicinebusinessEuropean heart journal
researchProduct

Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Ana…

2020

Abstract Purpose Chemoradiation (CT/RT) followed by radical surgery (RS) may play a role in locally advanced cervical cancer (LACC) patients with suboptimal response to CT/RT or in low-income countries with limited access to radiotherapy. Our aim is to evaluate oncological and surgical outcomes of minimally invasive radical surgery (MI-RS) compared with open radical surgery (O-RS). Patients and Methods Data for stage IB2–IVA cervical cancer patients managed by CT/RT and RS were retrospectively analyzed. Results Beginning with 686 patients, propensity score matching resulted in 462 cases (231 per group), balanced for FIGO stage, lymph node status, histotype, tumor grade, and clinical respons…

medicine.medical_specialtymedicine.medical_treatmentConcomitant Chemoradiation Neoadjuvant Chemotherapy Phase III Hysterectomy Radiation Therapy WomenUterine Cervical NeoplasmsHysterectomyDisease-Free Survival03 medical and health sciences0302 clinical medicinePhase IIIlocally advanced cervical cancer (LACC)locally advanced cervical cancerHumansMedicineWomenChemoradiotherapy; Disease-Free Survival; Female; Humans; Hysterectomy; Neoadjuvant Therapy; Neoplasm Recurrence Local; Neoplasm Staging; Propensity Score; Retrospective Studies; Uterine Cervical Neoplasms030212 general & internal medicineStage (cooking)Radical surgeryPropensity ScoreNeoadjuvant therapyNeoplasm StagingRetrospective StudiesCervical cancerHysterectomyRadiationbusiness.industrylocally advanced cervical cancer surgeryNeoadjuvant ChemotherapyRetrospective cohort studyChemoradiotherapyGynecologic Oncologymedicine.diseaseNeoadjuvant TherapySurgeryRadiation therapySettore MED/40 - GINECOLOGIA E OSTETRICIANeoplasm RecurrenceLocalOncology030220 oncology & carcinogenesisConcomitant ChemoradiationFemaleSurgeryTherapyNeoplasm Recurrence LocalbusinessChemoradiotherapy
researchProduct

The effect of radiotherapy on survival of dental implants in head and neck cancer patients

2016

Objectives: To explore the current literature of the survival of dental implants in irradiated head and neck cancer patients considering the role of implant location, bone augmentation, dose of radiation and timing of implant placement. Study Design: Pubmed search was conducted to identify articles published between January 2000 and December 2014 and presenting data of dental implant survival with radiotherapy in head and neck cancer patients. Studies on animal subjects and craniofacial implants were excluded. Results: 18 articles out of 27 were eligible for inclusion in this systematic review. 12 out of 18 studies reported favorable outcome of dental implants and radiotherapy with survival…

medicine.medical_specialtymedicine.medical_treatmentDentistryOdontologíaReview03 medical and health sciences0302 clinical medicinemedicineCraniofacialProspective cohort studyDental implantGeneral DentistrySurvival ratebusiness.industryHead and neck cancer030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryRadiation therapy030220 oncology & carcinogenesisMaxillaUNESCO::CIENCIAS MÉDICASImplantbusinessImplantology
researchProduct

Ureteroiliac Artery Fistula in a Young Woman with Short Bowel Syndrome for Radiation Enteritis

2010

Ureteral-iliac artery fistula is a rare and potentially life-threatening complication, typically occurring after radiation therapy in already surgically treated cancer patients. This case report describes the diagnostic challenges and the successful management, with the positioning of an intra-arterial prosthesis, of a fistula between the internal iliac artery and the left ureter presenting as massive hematuria in a young woman with history of total colectomy and pelvic radiotherapy for rectal cancer and subsequent wide ileal resections and bilateral ureteral stent positioning for radiation enteritis. Ureteroiliac artery fistulas require a prompt diagnosis and intervention, to avoid life th…

medicine.medical_specialtymedicine.medical_treatmentFistulalcsh:MedicineCase Reportshort bowel syndromeSettore MED/22 - Chirurgia Vascolaremedicine.arterymedicineRadiation Enteritisbusiness.industrylcsh:RUreteroiliac artery fistularadiation enteritis.StentGeneral Medicinemedicine.diseaseShort bowel syndromeHematuria Radiation Enteritis Short Bowel Syndrome Ureteroarterial fistula.Internal iliac arterySurgeryRadiation therapymedicine.anatomical_structureComplicationbusinessArteryCase Reports in Medicine
researchProduct

Increased risk of angiosarcoma secondary to cancer radiotherapy: Case series and review of the treatment options.

2020

Angiosarcomas (ASs) are aggressive tumors of vascular endothelial origin, occurring sporadically or in association with prior radiotherapy or chronic lymphedema. With only 1-5% of all sarcomas, the incidence seems low, but for the affected patient due to the extremely poor prognosis and the limited treatment options, the fate is often inevitable. Radiotherapy, chemotherapy, or "target therapy" have been used in the management of AS, but represent individual case decisions without lasting evidence. Over the past few years, breast-conserving surgery followed by radiation therapy, known as breast-conserving therapy (BCT), is being employed as a standard treatment for early-stage breast cancer,…

medicine.medical_specialtymedicine.medical_treatmentHemangiosarcomaBreast NeoplasmsDermatologyMastectomy Segmental030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineBreast cancermedicineHumansAngiosarcomaChemotherapybusiness.industryStandard treatmentIncidence (epidemiology)IncidenceTreatment optionsGeneral Medicinemedicine.diseasePrognosisRadiation therapy030220 oncology & carcinogenesisCancer RadiotherapyRadiologybusinessDermatologic therapyREFERENCES
researchProduct

Conservative Treatment of Splenic Haematoma After Colonoscopy: A Case Report

2020

Colonoscopy is a routine procedure performed worldwide, nevertheless, a small risk of splenic injury, often under-estimated, is still present. As a matter of fact, the diagnosis may be delayed, leading to a rising risk of morbidity and mortality. This paper describes a case of conservative treatment of colonoscopy-associated splenic injury. A 57-year-old woman presented with worsening pain in the upper left abdominal quadrant; she had radiation therapy to the ipsilateral subscapular region, and a diagnostic colonoscopy 18 hours earlier. The computed tomography (CT) scan revealed splenic laceration without signs of hemoperitoneum. Because of the hemodynamic stability of the patient, successf…

medicine.medical_specialtymedicine.medical_treatmentHemodynamicsColonoscopy030204 cardiovascular system & hematologyTrauma03 medical and health sciencesQuadrant (abdomen)0302 clinical medicinecolonoscopymedicineHemoperitoneumendoscopytraumatic injurymedicine.diagnostic_testbusiness.industryGastroenterologyGeneral EngineeringSurgeryEndoscopyRadiation therapyConservative treatmentTraumatic injuryhaematomaspleenmedicine.symptombusiness030217 neurology & neurosurgeryCureus
researchProduct

Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphpsphonates

2017

Introduction Chemotherapy-associated osteonecrosis of the jaw caused by bisphosphonates is an exposure of necrotic bone with more than eight weeks of evolution that is attributable to bisphosphonates and no prior radiation therapy. Its etiopathogenesis remains unknown, although there are two hypotheses that may explain it: the drug’s mechanism of action, and the risk factors that can lead to osteonecrosis. There is a wide range of treatment options for managing chemotherapy-associated osteonecrosis of the jaw, from conservative treatments to surgical procedures of varying levels of invasiveness, which are sometimes supplemented with adjuvant therapies. Objectives The objective of this artic…

medicine.medical_specialtymedicine.medical_treatmentMEDLINEAdministration OralReviewIntravenous bisphosphonates03 medical and health sciences0302 clinical medicineClinical ProtocolsmedicineHumansStage (cooking)General DentistryPrior Radiation TherapyOral Medicine and PathologyDiphosphonatesbusiness.industry030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryConservative treatmentOtorhinolaryngology030220 oncology & carcinogenesisRadiological weaponUNESCO::CIENCIAS MÉDICASAdministration IntravenousBisphosphonate-Associated Osteonecrosis of the JawSurgeryOsteonecrosis of the jawbusinessAdjuvant
researchProduct